Targimmune hero banner


At TargImmune, our mission is to significantly improve the survival of cancer patients.

We aim to improve survival rates by developing novel targeted anticancer therapeutics which provide a multi-pronged approach against solid tumours.

Survival rates image

The TargImmune team are dedicated to transforming the lives of cancer patients, and all those whose lives they touch, by bringing our proprietary, first-in-class, cancer-fighting Ta:RNA™ platform to the clinic.

Cancer cells

Our novel Ta:RNA™ platform is the first in a new class known as targeted apoptosis and immune modulators (TAIMs). It selectively destroys cancer cells by utilizing targeted nanoparticles to deliver double-stranded RNA and harness the human body’s powerful antiviral defence responses.


Latest Tweets